Skopos Labs, Inc. Liva Nova PLC Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Liva Nova PLC stock. As of the latest transaction made, Skopos Labs, Inc. holds 51 shares of LIVN stock, worth $2,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51
Previous 51
-0.0%
Holding current value
$2,750
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LIVN
# of Institutions
278Shares Held
55.4MCall Options Held
75.5KPut Options Held
79.5K-
Black Rock Inc. New York, NY6.9MShares$372 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.64MShares$250 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$132 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.43MShares$131 Million0.06% of portfolio
-
State Street Corp Boston, MA2.08MShares$112 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.89B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...